Raghwani J,McCrone S.C. .2022 .Genomic epidemiology of early SARS-CoV-2 transmission dynamics. , : .
Infect Emerg. . .. , 28 : 751-758.
Zhang G.,Zeng H.,Pan C.,Li Y.,Hu Y. .2020 .. , : .
. .Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: A randomised, double-blind, placebo-controlled, phase 1/2 clinical trial. Lancet Infect. Dis., 21 : 181-192.
Malik J.A,Ahmed S.,Mir A.,Shinde M.,Bender O. .2022 .The SARS-CoV-2 mutations versus vaccine effectiveness: New opportunities to new challenges.. , : .
Infect J. . .. , 15 : 228-240.
Brito AF,Kalinich C.C. .2022 .Global disparities in SARS-CoV-2 genomic surveillance. Nat. Commun, 13(10) : 541467.
Saravanan KA,Panigrahi M.,Kumar H.,Rajawat D.,Nayak S.S.,Bhushan B.,Dutt T. .2022 .Role of genomics in combating COVID-19 pandemic. , 823 : .
.2022 .. , 146387 : .
Hodcroft EB,Zuber M.,Nadeau S.,Vaughan and KH.D. T.G. .2021 .Spread of a SARS-CoV-2 variant through Europein the summer of 2020. , 595 : 707-712.
Greaney AJ,Binshtein E. .2021 .Complete mapping of mutations to the SARS-CoV-2 spike receptor-binding domain that escape antibody recognition. Cell Host Microbe, 29 : 44-57.
Liu Y.,J. Rockl6v Y. .2021 .The reproductive number of the Delta variant of SARS-CoV-2 is far higher compared to the ancestral SARS-CoV-2 virus. J. Travel Med, 28 : .
. .. , : .
Plante J.A,Xia H.,Johnson B.A. .2021 .. , : .
. .Spike mutation D614G alters SARS-CoV-2 fitness. Nature, 592 : 116-121.
Harvey ,A.M. Carabelli B,Jackson RK .2021 .SARS-CoV-2 variants, spike mutations and immune escape. Nat. Rev. Microbiol., 19 : 409-424.
Alpert T.,M.E. Petrone etal T. .2021 .Multiplex gPCR discriminvaatrieansts of concern to enhance global surveillance of SARS-CoV-2. , 3001236 : .
He D.,Chen B.,Zhao S.,Stone L. .2023 .The immune evasion ability of Delta variant is comparabl eto that of Beta variant in South Africa. BMC Public Health, 23 : .
Li H.,Song J.,Rahmati M.,Park S. .2023 .. , : .
. .Genetics, structure, transmission, epidemiology, immune response, and vaccine efficacies of the SARS-CoV-2 Delta variant: A comprehensive review. Rev. Med, 33 : .
. .. , : .
Chan KC,Song Y.,Xu Z.,Shang C.,Zhou R. .2022 .. , : .
. .SARS-CoV-2 Delta variant: Interplay between individual mutatianod ntsheir allosteric synergy. Biomolecules, 12 : .
. .. , : .
Zabidi N.Z,Farouk A. .2023 .Evolution of SARS-CoV-2 variants: Implicationsonimmune escape, vaccination, therapeutic and diagnostic strategies. Viruses, 15 : .
Dubey A,Kumar P.,Tomar S. .2022 .. , : .
Emerging . .2 variants: Genetic variability and clinical ~ implications. , 79 : .
McCormick KD .2021 .. JL. Jacobs and JW. Mellors, : .
. .The emerging plasticity of SARS-CoV-2: The evolution of SARS-CoV-2 poses challenges for vaccines and immunotherapies. Science, 371 : 1306-1308.
Chowdhury S.,Chowdhury S.,Chowdhury M.S.,Chowdhury N.S. .2021 .Current review of Delta variant of SARS-CoV-2. J. Med. Health Sci, 3 : 23-29.
Gupta P,Singh CM.,Singhal L. .2023 .. , : .
. .. Emergence of COVID-19 variants: An update. Cureus, 15 : .
. .. , : .
Gerardi V.,Atasoy M.O.,Munir M. .2023 .Deep structural analysis of myriads of omicron sub-variants revealed hotspot for vaccine escape immunity. Vaccines, 11 : .
Kumar A,Asghar A.,Singh H.N.,Faiqand S.Kumar M.A. .2023 .SARS-CoV-2 omicron variant genomic sequences and their epidemiological correlates regarding the end of the pandemic: /n silico analysis. MIR Bioinf. Biotech., 4 : .
Krammer F. .2020 .SARS-CoV-2 vaccines in development.. , : .
Nature . .. , 586 : 516-527.
Hatcher EL,Zhdanov SA,Bao Y.,Blinkova O.,Nawrocki E.P. .2017 .Virus variation resource-improved response to emergent viral outbreaks. Nucleic Acids Res, 45 : D482-D490.